These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 3083105

  • 21. Peritoneal cell populations during tumour injection.
    De Heer E, De Groot JW, Den Otter W, Dullens HF.
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [Abstract] [Full Text] [Related]

  • 22. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML, Parenza M, Parmiani G.
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [Abstract] [Full Text] [Related]

  • 23. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 24. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells.
    Schick B, Berke G.
    J Immunol; 1977 Mar; 118(3):986-91. PubMed ID: 321684
    [Abstract] [Full Text] [Related]

  • 25. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID.
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [Abstract] [Full Text] [Related]

  • 26. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 27. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y, Tashiro-Yamaji J, Kubota T, Yoshida R.
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [Abstract] [Full Text] [Related]

  • 28. Demonstration in vitro of cytotoxic T cells with apparent specificity toward tumor-specific transplantation antigens on chemically induced tumors.
    Chauvenet PH, McArthur CP, Smith RT.
    J Immunol; 1979 Dec; 123(6):2575-81. PubMed ID: 315425
    [Abstract] [Full Text] [Related]

  • 29. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
    Benjamini E, Fong S, Erickson C, Leung CY, Rennick D, Scibienski RJ.
    J Immunol; 1977 Feb; 118(2):685-93. PubMed ID: 839074
    [Abstract] [Full Text] [Related]

  • 30. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
    Koyama S, Yoshioka T, Sakita T.
    Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
    [Abstract] [Full Text] [Related]

  • 31. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 32. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T, Igarashi T, Kishimoto S.
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [Abstract] [Full Text] [Related]

  • 33. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
    Zietman AL, Suit HD, Ramsay JR, Silobrcic V, Sedlacek RS.
    Cancer Res; 1988 Nov 15; 48(22):6510-6. PubMed ID: 3052803
    [Abstract] [Full Text] [Related]

  • 34. [Effects of levamisole on methylcholanthrene-induced tumor. II. Potentiation of cytotoxic T-cell activities].
    Gomi K, Morimoto M, Nomoto K.
    Gan To Kagaku Ryoho; 1982 Jul 15; 9(7):1269-76. PubMed ID: 6985196
    [Abstract] [Full Text] [Related]

  • 35. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb 15; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

  • 36. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N, Saito M, Nanjo M.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [Abstract] [Full Text] [Related]

  • 37. Natural cytostatic cells have a broader range of antitumor activity than natural killer cells.
    Kato M, Kawauchi H, Taniguchi K, Katsuki T, Nomoto K.
    J Clin Lab Immunol; 1985 Jan 15; 16(1):47-51. PubMed ID: 3872372
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 15; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 39. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC, Law LW.
    J Immunol; 1977 Apr 15; 118(4):1259-64. PubMed ID: 191534
    [Abstract] [Full Text] [Related]

  • 40. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH, Anderson AB.
    Cancer Res; 1988 Mar 15; 48(6):1398-403. PubMed ID: 3257896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.